Manish Chapekar
Directeur/Bestuurslid bij Kanisa Pharmaceuticals, Inc.
Profiel
Mr. Manish Chapekar is on the Board of Directors at Kanisa Pharmaceuticals, Inc. and moksha8 Pharmaceuticals, Inc.
Mr. Chapekar was previously employed as a Managing Director by Montreux Equity Partners, Inc. He also served on the board at Glaukos Corp.
and Percutaneous Systems, Inc.
He received his undergraduate degree from the Indian Institute of Technology Bombay, a graduate degree from the University of Kentucky, and an MBA from Stanford University.
Actieve functies van Manish Chapekar
| Bedrijven | Functie | Begin |
|---|---|---|
Kanisa Pharmaceuticals, Inc.
 Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Manish Chapekar
| Bedrijven | Functie | Einde |
|---|---|---|
Montreux Equity Partners, Inc.
 Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | Chief Investment Officer | 31-05-2011 |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Directeur/Bestuurslid | - |
| GLAUKOS CORPORATION | Directeur/Bestuurslid | - |
Percutaneous Systems, Inc.
 Percutaneous Systems, Inc. Medical SpecialtiesHealth Technology Percutaneous Systems, Inc. designs, develops, and commercializes medical devices. Its PercSys Accordion Stone Management Device and the Accordion CoAx Stone Control Devices are designed to simplify and shorten endoscopic lithotripsy procedures by combining the utility of multiple endoscopic stone management tools into a single device. The company was founded by Robert Behl in 2003 and is headquartered in Palo Alto, CA. | Directeur/Bestuurslid | - |
Opleiding van Manish Chapekar
| Stanford University | Masters Business Admin |
| University of Kentucky | Graduate Degree |
| Indian Institute of Technology Bombay | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GLAUKOS CORPORATION | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Kanisa Pharmaceuticals, Inc.
Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA. | Health Technology |
Percutaneous Systems, Inc.
Percutaneous Systems, Inc. Medical SpecialtiesHealth Technology Percutaneous Systems, Inc. designs, develops, and commercializes medical devices. Its PercSys Accordion Stone Management Device and the Accordion CoAx Stone Control Devices are designed to simplify and shorten endoscopic lithotripsy procedures by combining the utility of multiple endoscopic stone management tools into a single device. The company was founded by Robert Behl in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
Montreux Equity Partners, Inc.
Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California. | Finance |
